Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery – dual uptake through enterocytes and M-cells

References

• SmorenburgCHSparreboomAOral anticancer agentsPinedoHMSmorenburgCHDrugs Affecting Growth of TumoursBaselBirkhäuser Verlag2006153166
   Google Scholar
• MeiLZhangZZhaoLPharmaceutical nanotechnology for oral delivery of anticancer drugsAdv Drug Deliv Rev201365688089023220325
   PubMed Web of Science ®Google Scholar
• StuurmanFENuijenBBeijnenJHSchellensJHOral anticancer drugs: mechanisms of low bioavailability and strategies for improvementClin Pharmacokinet201352639941423420518
   PubMed Web of Science ®Google Scholar
• RosePGBlessingJAMayerARHomesleyHDProlonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group studyJ Clin Oncol19981624054109469322
   PubMed Web of Science ®Google Scholar
• GrazianoMJPilcherGDWalshKMKasaliOBRadulovicLPreclinical toxicity of a new oral anticancer drug, CI-994 (acetyldinaline), in rats and dogsInvest New Drugs19971542953109547672
   PubMed Web of Science ®Google Scholar
• ThankiKGangwalRPSangamwarATJainSOral delivery of anticancer drugs: challenges and opportunitiesJ Control Release20131701154023648832
   PubMed Web of Science ®Google Scholar
• SparreboomAvan AsperenJMayerULimited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineProc Natl Acad Sci U S A1997945203120359050899
   PubMed Web of Science ®Google Scholar
• MalingréMMBeijnenJHSchellensJHOral delivery of taxanesInvest New Drugs200119215516211392449
   PubMed Web of Science ®Google Scholar
• GreishKSawaTFangJAkaikeTMaedaHSMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumoursJ Control Release200497221923015196749
   PubMed Web of Science ®Google Scholar
• MiyataKChristieRJKataokaKPolymeric micelles for nano-scale drug deliveryReact Funct Polym2011713227234
   Web of Science ®Google Scholar
• DaruwallaJNikfarjamMGreishKIn vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastasesCancer Sci201010181866187420579075
   PubMedGoogle Scholar
• NehoffHParayathNTaurinSGreishKThe influence of drug loading on caveolin-1 mediated intracellular internalization of doxorubicin nanomicelles in vitroJ Nanomed Nanotechnol201451972
   Google Scholar
• VichaiVKirtikaraKSulforhodamine B colorimetric assay for cytotoxicity screeningNat Protoc2006131112111617406391
   PubMed Web of Science ®Google Scholar
• MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
   PubMed Web of Science ®Google Scholar
• BartheLWoodleyJFKenworthySHouinGAn improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestineEur J Drug Metab Pharmacokinet19982323133239725499
   PubMedGoogle Scholar
• NorrisBPritchardKIJamesKPhase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8J Clin Oncol200018122385239410856098
   PubMed Web of Science ®Google Scholar
• ParidaensRBiganzoliLBruningPPaclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer randomized study with cross-overJ Clin Oncol200018472473310673513
   PubMed Web of Science ®Google Scholar
• BrambillaCRossiABonfanteVPhase II study of doxorubicin versus epirubicin in advanced breast cancerCancer Treat Rep19867022612663456271
   PubMedGoogle Scholar
• IqbalJSartiFPereraGBernkop-SchnürchADevelopment and in vivo evaluation of an oral drug delivery system for paclitaxelBiomaterials201132117017520926128
   PubMed Web of Science ®Google Scholar
• BradleyMOSwindellCSAnthonyFHTumor targeting by conjugation of DHA to paclitaxelJ Control Release2001741–323323611489499
   PubMed Web of Science ®Google Scholar
• DubeANicolazzoJALarsonIChitosan nanoparticles enhance the plasma exposure of (−)-epigallocatechin gallate in mice through an enhancement in intestinal stabilityEur J Pharm Sci201144342242621925598
   PubMed Web of Science ®Google Scholar
• WiwattanapatapeeRCarreño-GómezBMalikNDuncanRAnionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system?Pharm Res200017899199811028947
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• ElsabahyMWooleyKLDesign of polymeric nanoparticles for biomedical delivery applicationsChem Soc Rev20124172545256122334259
   PubMed Web of Science ®Google Scholar
• LiLGaoFPTangHBSelf-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicinNanotechnology2010212626560120522924
   PubMedGoogle Scholar
• IyerAKGreishKFangJMurakamiRMaedaHHigh-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitorBiomaterials200728101871188117208294
   PubMedGoogle Scholar
• HörterDDressmanJBInfluence of physicochemical properties on dissolution of drugs in the gastrointestinal tractAdv Drug Deliv Rev2001461–3758711259834
   PubMed Web of Science ®Google Scholar
• DeryckeASde WittePALiposomes for photodynamic therapyAdv Drug Deliv Rev2004561173014706443
   PubMed Web of Science ®Google Scholar
• ShiGGuoWStephensonSMLeeRJEfficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinationsJ Control Release2002801–330931911943407
   PubMed Web of Science ®Google Scholar
• IwanagaKOnoSNariokaKOral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tractInt J Pharm199715717380
   Web of Science ®Google Scholar
• GlückSAdjuvant chemotherapy for early breast cancer: optimal use of epirubicinOncologist2005101078079116314288
   PubMed Web of Science ®Google Scholar
• ThornCFOshiroCMarshSDoxorubicin pathways: pharmacodynamics and adverse effectsPharmacogenet Genomics201121744021048526
   PubMed Web of Science ®Google Scholar
• SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
   PubMed Web of Science ®Google Scholar
• ZhaoQHanBWangZGaoCPengCShenJHollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studiesNanomedicine200731637417379170
   PubMed Web of Science ®Google Scholar
• Ten HagenTLVan Der VeenAHNooijenPTVan TielSTSeynhaeveALEggermontAMLow-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing ratsInt J Cancer200087682983710956394
   PubMedGoogle Scholar
• BrouckaertPTakahashiNvan TielSTTumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokineticsInt J Cancer2004109344244814961585
   PubMedGoogle Scholar
• DiLArturssonPAvdeefAEvidence-based approach to assess passive diffusion and carrier-mediated drug transportDrug Discov Today20121715–1690591222507594
   PubMedGoogle Scholar
• LoYLiuFCherngJEffect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestinesJ Control Release2001761–211011532308
   PubMedGoogle Scholar
• LoYLPhospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of ratsBiochem Pharmacol20006091381139011008132
   PubMed Web of Science ®Google Scholar
• SaremiSAtyabiFAkhlaghiSPOstadSNDinarvandRThiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluationInt J Nanomedicine2011611912821289989
   PubMed Web of Science ®Google Scholar
• PukanudPPeungvichaPSarisutaNDevelopment of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer’s patchesDrug Deliv200916528929419538011
   PubMed Web of Science ®Google Scholar
• VollrathASchallonAPietschCA toolbox of differently sized and labeled PMMA nanoparticles for cellular uptake investigationsSoft Matter20139199108
   Web of Science ®Google Scholar
• WatsonPJonesATStephensDJIntracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cellsAdv Drug Deliv Rev2005571436115518920
   PubMed Web of Science ®Google Scholar
• IversenTGSkotlandTSandvigKEndocytosis and intracellular transport of nanoparticles: present knowledge and need for future studiesNano Today201162176185
   Web of Science ®Google Scholar
• VogelUSandvigKvan DeursBExpression of caveolin-1 and polarized formation of invaginated caveolae in Caco-2 and MDCK II cellsJ Cell Sci1998111Pt 68258329472010
   PubMedGoogle Scholar
• El-SayedMRhodesCAGinskiMGhandehariHTransport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayersInt J Pharm20032651–215115714522128
   PubMed Web of Science ®Google Scholar
• SchipperNGOlssonSHoogstraateJAdeBoerAGVårumKMArturssonPChitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancementPharm Res19971479239299244151
   PubMed Web of Science ®Google Scholar
• TurnerJRIntestinal mucosal barrier function in health and diseaseNat Rev Immunol200991179980919855405
   PubMed Web of Science ®Google Scholar
• YuTGreishKMcGillLDRayAGhandehariHInfluence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance thresholdACS Nano2012632289230122364198
   PubMed Web of Science ®Google Scholar
• YáñezJAWangSWKnemeyerIWWirthMAAltonKBIntestinal lymphatic transport for drug deliveryAdv Drug Delivery Rev20116310–11923942
   PubMed Web of Science ®Google Scholar
• KunisawaJKurashimaYKiyonoHGut-associated lymphoid tissues for the development of oral vaccinesAdv Drug Deliv Rev201264652353021827802
   PubMed Web of Science ®Google Scholar
• LingSSMagossoEKhanNAYuenKHBarkerSAEnhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomesDrug Dev Ind Pharm200632333534516556538
   PubMed Web of Science ®Google Scholar
• ErmundASchütteAJohanssonMEGustafssonJKHanssonGCStudies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patchesAm J Physiol Gastrointest Liver Physiol20133055G341G34723832518
   PubMed Web of Science ®Google Scholar
• ShakwehMPonchelGFattalEParticle uptake by Peyer’s patches: a pathway for drug and vaccine deliveryExpert Opin Drug Deliv20041114116316296726
   PubMedGoogle Scholar